Britain’s AstraZeneca Starts Trial of Antibody Treatment for Covid-19

AstraZeneca said on Tuesday it started early stage trials for an antibodybased treatment for the prevention and treatment of COVID19, as the British drugmaker also ploughs on with its vaccine candidate.

Read the Rest at News18

Leave a Reply

Your email address will not be published. Required fields are marked *